Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
82.9K
-
Shares change
-
+12.3K
-
Total reported value, excl. options
-
$284K
-
Value change
-
+$31.8K
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$3.43
Significant Holders of Protagenic Therapeutics, Inc.\new - COM (PTIX) as of Q3 2025
13 filings reported holding PTIX - Protagenic Therapeutics, Inc.\new - COM as of Q3 2025.
Protagenic Therapeutics, Inc.\new - COM (PTIX) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 82.9K shares
.
Largest 10 shareholders include DRW Securities, LLC (36.2K shares), Connective Capital Management, LLC (28.6K shares), MORGAN STANLEY (15K shares), CITIGROUP INC (1.78K shares), Tower Research Capital LLC (TRC) (1.24K shares), UBS Group AG (56 shares), United Financial Planning Group LLC (17 shares), BANK OF AMERICA CORP /DE/ (8 shares), HARBOR INVESTMENT ADVISORY, LLC (1 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (0 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.